☰

Thomas Carlsson - Publications

Affiliations: 
Lund University, Lund, Skåne län, Sweden 
Tree Info Grants Similar researchers PubMed Report error

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Klietz M, Keber U, Carlsson T, Chiu WH, Höglinger GU, Weihe E, Schäfer MK, Depboylu C. L-DOPA-induced dyskinesia is associated with a deficient numerical downregulation of striatal tyrosine hydroxylase mRNA-expressing neurons. Neuroscience. PMID 27320210 DOI: 10.1016/J.Neuroscience.2016.06.017  0.418
2015 Keber U, Klietz M, Carlsson T, Oertel WH, Weihe E, Schäfer MKH, Höglinger GU, Depboylu C. Striatal tyrosine hydroxylase-positive neurons are associated with l-DOPA-induced dyskinesia in hemiparkinsonian mice Neuroscience. 298: 302-317. PMID 25892702 DOI: 10.1016/j.neuroscience.2015.04.021  0.465
2015 Mitra R, Aronsson P, Winder M, Tobin G, Bergquist F, Carlsson T. Local Change in Urinary Bladder Contractility Following CNS Dopamine Denervation in the 6-OHDA Rat Model of Parkinson's Disease. Journal of Parkinson's Disease. PMID 25697958 DOI: 10.3233/JPD-140509  0.321
2014 Brehm N, Bez F, Carlsson T, Kern B, Gispert S, Auburger G, Cenci MA. A Genetic Mouse Model of Parkinson's Disease Shows Involuntary Movements and Increased Postsynaptic Sensitivity to Apomorphine. Molecular Neurobiology. PMID 25307288 DOI: 10.1007/s12035-014-8911-6  0.314
2014 Chiu WH, Carlsson T, Depboylu C, Höglinger GU, Oertel WH, Ries V. Selegiline normalizes, while l-DOPA sustains the increased number of dopamine neurons in the olfactory bulb in a 6-OHDA mouse model of Parkinson's disease. Neuropharmacology. 79: 212-21. PMID 24291466 DOI: 10.1016/J.Neuropharm.2013.11.014  0.521
2013 Prinz A, Selesnew LM, Liss B, Roeper J, Carlsson T. Increased excitability in serotonin neurons in the dorsal raphe nucleus in the 6-OHDA mouse model of Parkinson's disease. Experimental Neurology. 248: 236-45. PMID 23810738 DOI: 10.1016/J.Expneurol.2013.06.015  0.563
2013 Langer F, Garcia J, Carlsson T, Nikkhah G, Winkler C. Extrastriatal dopamine degeneration and dopaminergic grafts for the development of L-DOPA-induced dyskinesia Basal Ganglia. 3: 45-46. DOI: 10.1016/J.Baga.2013.01.019  0.748
2012 García J, Carlsson T, Döbrössy M, Nikkhah G, Winkler C. Impact of dopamine versus serotonin cell transplantation for the development of graft-induced dyskinesia in a rat Parkinson model. Brain Research. 1470: 119-29. PMID 22759908 DOI: 10.1016/J.Brainres.2012.06.029  0.752
2012 Chiu W, Carlsson T, Arend M, Höglinger G, Oertel W, Ries V. 3.146 MODULATION OF ADULT NEUROGENESIS IN THE OLFACTORY BULB IN AN ACUTE MOUSE MODEL OF PARKINSON'S DISEASE Parkinsonism & Related Disorders. 18: S200. DOI: 10.1016/S1353-8020(11)70862-8  0.326
2011 García J, Carlsson T, Döbrössy M, Nikkhah G, Winkler C. Extent of pre-operative L-DOPA-induced dyskinesia predicts the severity of graft-induced dyskinesia after fetal dopamine cell transplantation. Experimental Neurology. 232: 270-9. PMID 21946270 DOI: 10.1016/J.Expneurol.2011.09.017  0.759
2011 García J, Carlsson T, Döbrössy M, Nikkhah G, Winkler C. Impact of dopamine to serotonin cell ratio in transplants on behavioral recovery and L-DOPA-induced dyskinesia. Neurobiology of Disease. 43: 576-87. PMID 21600983 DOI: 10.1016/J.Nbd.2011.05.004  0.747
2011 Carlsson T, Schindler FR, Höllerhage M, Depboylu C, Arias-Carrión O, Schnurrbusch S, Rösler TW, Wozny W, Schwall GP, Groebe K, Oertel WH, Brundin P, Schrattenholz A, Höglinger GU. Systemic administration of neuregulin-1β1 protects dopaminergic neurons in a mouse model of Parkinson's disease. Journal of Neurochemistry. 117: 1066-74. PMID 21517849 DOI: 10.1111/J.1471-4159.2011.07284.X  0.586
2010 Carta M, Carlsson T, Muñoz A, Kirik D, Björklund A. Role of serotonin neurons in the induction of levodopa- and graft-induced dyskinesias in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: S174-9. PMID 20187238 DOI: 10.1002/Mds.22792  0.771
2010 Björklund T, Carlsson T, Cederfjäll EA, Carta M, Kirik D. Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson's disease. Brain : a Journal of Neurology. 133: 496-511. PMID 20129936 DOI: 10.1093/Brain/Awp314  0.753
2009 Björklund T, Hall H, Breysse N, Soneson C, Carlsson T, Mandel RJ, Carta M, Kirik D. Optimization of continuous in vivo DOPA production and studies on ectopic DA synthesis using rAAV5 vectors in Parkinsonian rats. Journal of Neurochemistry. 111: 355-67. PMID 19686242 DOI: 10.1111/J.1471-4159.2009.06340.X  0.773
2009 Muñoz A, Carlsson T, Tronci E, Kirik D, Björklund A, Carta M. Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model. Experimental Neurology. 219: 298-307. PMID 19500572 DOI: 10.1016/J.Expneurol.2009.05.033  0.706
2009 Leriche L, Björklund T, Breysse N, Besret L, Grégoire MC, Carlsson T, Dollé F, Mandel RJ, Déglon N, Hantraye P, Kirik D. Positron emission tomography imaging demonstrates correlation between behavioral recovery and correction of dopamine neurotransmission after gene therapy. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 1544-53. PMID 19193901 DOI: 10.1523/Jneurosci.4491-08.2009  0.774
2009 Carlsson T, Carta M, Muñoz A, Mattsson B, Winkler C, Kirik D, Björklund A. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration. Brain : a Journal of Neurology. 132: 319-35. PMID 19039008 DOI: 10.1093/Brain/Awn305  0.803
2008 Lundberg C, Björklund T, Carlsson T, Jakobsson J, Hantraye P, Déglon N, Kirik D. Applications of lentiviral vectors for biology and gene therapy of neurological disorders. Current Gene Therapy. 8: 461-73. PMID 19075629 DOI: 10.2174/156652308786847996  0.742
2008 Muñoz A, Li Q, Gardoni F, Marcello E, Qin C, Carlsson T, Kirik D, Di Luca M, Björklund A, Bezard E, Carta M. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia. Brain : a Journal of Neurology. 131: 3380-94. PMID 18952677 DOI: 10.1093/Brain/Awn235  0.728
2008 Carta M, Carlsson T, Muñoz A, Kirik D, Björklund A. Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias. Progress in Brain Research. 172: 465-78. PMID 18772046 DOI: 10.1016/S0079-6123(08)00922-9  0.763
2008 Carta M, Carlsson T, Muñoz A, Kirik D, Björklund A. Involvement of the serotonin system in L-dopa-induced dyskinesias. Parkinsonism & Related Disorders. 14: S154-8. PMID 18579429 DOI: 10.1016/J.Parkreldis.2008.04.021  0.776
2008 Lane EL, Carlsson T, Kirik D, Dunnett SB. Animal models of Parkinson's disease Source Book of Models For Biomedical Research. 313-322. DOI: 10.1007/978-1-59745-285-4_34  0.739
2007 Carlsson T, Carta M, Winkler C, Björklund A, Kirik D. Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 8011-22. PMID 17652591 DOI: 10.1523/Jneurosci.2079-07.2007  0.805
2007 Breysse N, Carlsson T, Winkler C, Björklund A, Kirik D. The functional impact of the intrastriatal dopamine neuron grafts in parkinsonian rats is reduced with advancing disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 5849-56. PMID 17537955 DOI: 10.1523/Jneurosci.0626-07.2007  0.796
2007 Carta M, Carlsson T, Kirik D, Björklund A. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. Brain : a Journal of Neurology. 130: 1819-33. PMID 17452372 DOI: 10.1093/Brain/Awm082  0.777
2007 Carlsson T, Björklund T, Kirik D. Restoration of the striatal dopamine synthesis for Parkinson's disease: viral vector-mediated enzyme replacement strategy. Current Gene Therapy. 7: 109-20. PMID 17430130 DOI: 10.2174/156652307780363125  0.734
2006 Winkler C, Georgievska B, Carlsson T, Lacar B, Kirik D. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats. Neuroscience. 141: 521-31. PMID 16697115 DOI: 10.1016/J.Neuroscience.2006.03.068  0.739
2006 Carlsson T, Winkler C, Lundblad M, Cenci MA, Björklund A, Kirik D. Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia. Neurobiology of Disease. 21: 657-68. PMID 16256359 DOI: 10.1016/J.Nbd.2005.09.008  0.729
2005 Carlsson T, Winkler C, Burger C, Muzyczka N, Mandel RJ, Cenci A, Björklund A, Kirik D. Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors. Brain : a Journal of Neurology. 128: 559-69. PMID 15659429 DOI: 10.1093/Brain/Awh374  0.819
2005 Winkler C, Carlsson T, Burger C, Muzyczka N, Mandel R, Cenci A, Björklund A, Dengler R, Kirik D. Normalisierung der striatalen Genexpression und Reduktion L-DOPA-induzierter Dyskinesien durch viralen Gentransfer im Tiermodell der Parkinson'schen Erkrankung Aktuelle Neurologie. 32. DOI: 10.1055/S-2005-866631  0.703
2005 Georgievska B, Winkler C, Carlsson T, Lacar B, Kirik D. 941. Delayed GDNF Exposure to Mature Dopaminergic Grafts Impairs Their Ability To Improve Motor Function in Parkinsonian Rats Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.484  0.716
2004 Georgievska B, Carlsson T, Lacar B, Winkler C, Kirik D. Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor. The European Journal of Neuroscience. 20: 3121-30. PMID 15579166 DOI: 10.1111/J.1460-9568.2004.03770.X  0.707
2004 Winkler C, Carlsson T, Burger C, Muzyczka N, Mandel R, Cenci A, Dengler R, Björklund A, Kirik D. Reversal of L-DOPA-induced dyskinesia by recombinant AAV-mediated gene transfer Aktuelle Neurologie. 31. DOI: 10.1055/S-2004-833029  0.68
Show low-probability matches.